A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Clinical trial NCT06575426 · RECRUITING

Trial details

NCT number: NCT06575426
Sponsor: Otsuka Pharmaceutical Factory, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Hypoglycemia Islet Cell Transplantation Type 1 Diabetes Type 1 Diabetes Mellitus T1D T1DM T1DM - Type 1 Diabetes Mellitus Type 1 Diabetes (T1D)Severe Hypoglycemia Xenotransplantation Hypoglycemic Episode

Start date: 2025-06-10
Primary completion: 2027-06-30
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.